Bhola et al. found that chemotherapy-induced TGF-β caused tumor recurrence through IL-8 in CSCs, as TGF-β enhanced the stemness of the breast cancer cells; moreover, TGF-β type I receptor kinase inhibitors prevented the development of drug-resistant CSCs [36]. Here, TGFB1 is linked to breast cancer.